Researchers from Ineos Oxford Institute for antimicrobial research (IOI) have discovered that cephalosporins, a widely used class of antibiotics, can block a key enzyme that SARS-CoV-2 needs to replicate - 120 compounds were investigated.
👉Read more: https://ow.ly/xGMm50Z73To
